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Scope 
of this talk: 
review & update 
of the high-quality 
scientific work 
in the field of equine 
genomics in Europe 
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Background 
 long tradition of horse breeding in Europe 
 multiple breeds and studbooks 
 across and within countries 
 structural heterogeneity 
 intense exchange of genetic material (internationalization) 
 breeding programs 
 routine assessments of breeding stock (foals, mares, stallions) 
 highly developed performance testing systems 
 genetic evaluations for conformation and performance traits 
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STRONG GENETIC RESEARCH 
IN HORSES IN EUROPE 
Challenges 
 spectrum of traits 
 late availability of phenotype information 
 e.g. sport performance 
 limited access to reliable indicator traits 
 e.g. stallion performance tests 
 lacking information on important phenotypes 
 e.g. health 
 approaches to speed up the genetic progress 
 shortening the long generation interval 
  earlier access to reliable predictions of genetic merit 
 increase of selection intensity for important traits 
  particularly for the challenging breeding goal traits 
 (low h², difficult and limited access to phenotypes) 
 high potential of using genomic tools in horses 
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G = (i * r * a) / L 
with G = genetic change, a = genetic 
variability of the trait, i = selection 
intensity, r = accuracy of selection, 
L=generation interval (Falconer 1989) 
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Research framework in Europe 
 multi-center molecular genetic / genomic research in equids 
 relevant role in the worldwide genome research network 
 internationally recognized scientists and working groups 
 linking of expertise 
 efficient use of resources 
 collaboration of science and industry as crucial factor 
 strong equine sector benefitting equine (genomic) research 
 optimum use of genomic tools 
 strategies for studying hereditary conditions 
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STRONG GENOMIC RESEARCH 
IN HORSES IN EUROPE 
Areas of genomic research 
 analyses of genome-wide genetic markers (BeadChip analyses) 
 Sanger sequencing, Next Generation Sequencing (NGS) 
 horse genome assembly (EquCab 3.0) 
 population genomics 
 genome wide association studies (GWAS) 
 mutation analyses 
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Horse genome sequence 
 'The Horse Genome Project' 
 international consortium: 
 100 researchers from > 20 countries 
 start in 1995, sequence publicly available in 
January 2007: EquCab1.0 
 EquCab2.0 
 Whole Genome Shotgun (WGS) assembly at 6.8X 
 sequencing of individuals from multiple breeds 
  SNP library, 50k SNP chip 
 EquCab3.0 
 high-throughput Illumina data (42X) 
 leverage of long and short read data (NGS) 
 for new assembly 
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Basis of references genomes: 
'Twilight' (top, photo: NHGRI), 
halfbrother 'Bravo' and 'Hrafnhetta'  
Wade et al. (2009). Science 326, 865-867. Kalbfleisch et al. (2014). PAG XXII Conference, Jan 10-15, 2014, W279.  




Genome sequence  genomic tools (I) 
 key facts for further research 
 linkage disequilibrium (LD): 
 moderate within breeds 
 LDhuman < LDhorse < LDdog 
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Wade et al. (2009). Science 326, 865-867. Mikko et al. (2010). WCGALP, Aug 1-8, 2010, No.898. McCue et al. (2012). PLoS Genet 8, e1002451. 
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Genome sequence  genomic tools (II) 
 key facts for further research 
 linkage disequilibrium (LD): 
 moderate within breeds 
 LDhuman < LDhorse < LDdog 
 impact of domestication 
 differences between breeds / breed groups 
JAM 2014, Equine genomic research (STOCK et al.) 8 
Wade et al. (2009). Science 326, 865-867. Mikko et al. (2010). WCGALP, Aug 1-8, 2010, No.898. McCue et al. (2012). PLoS Genet 8, e1002451. 
Source: Mikko et al., 2010.  
Genome sequence  genomic tools (III) 
 key facts for further research 
 linkage disequilibrium (LD): 
 moderate within breeds 
 LDhuman < LDhorse < LDdog 
 impact of domestication 
 differences between breeds / breed groups 
 whole-genome SNP chips 
 Illumina 50k, 70k 
 Affimetrix HD (by the end of 2014) 
 implications: 
 facilitated shift of research focus from 
 monogenic to multi-/polygenic traits 
 perspective for routine applications in horse breeding 
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Wade et al. (2009). Science 326, 865-867. Mikko et al. 2010). WCGALP, Aug 1-8, 2010, No.898. McCue et al. (2012). PLoS Genet 8, e1002451. 
Source: Mikko et al., 2010.  
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Target traits 
 conformation and functionality 
 body size and shape 
 conformational defects 
 health and disease 
 skeleton and locomotor system 
 neurological function 
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BREEDING GOAL TRAITS 
IN THE FOCUS OF  
EQUINE GENOMIC RESEARCH  
Photo: http://wwwwbfsh.org 
Conformation and functionality 
Body size 
 model trait for studying genetic influences 
 on quantitative traits (within and across species) 
 importance across breeds of horses 
 distinct types of equine skeletal morphology 
 specific body size and shape variation patterns 
 within and across breeds 
 increase of knowledge on genetic size regulation 
- particularly fast since 2012 
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Conformation and functionality 
Body size: WH (I) 
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 1,077 Franches-Montages horses 
 212 stallions, 865 broodmares 
 withers height of 145-165cm; 
deregressed EBV for withers height 
 Illumina EquineSNP50® BeadChip 
 (54,602  38,124 SNPs) 
 QTL regions on ECA3 (LCORL/NCAPG) 
and ECA9 (ZFAT) together 
 explaining 18.2% of dEBV variance 
May 2012 
Conformation and functionality 
Body size: WH (II) 
JAM 2014, Equine genomic research (STOCK et al.) 13 
 782 young German WB stallions 
 Hol. (N=333), Old. (N=213), Han. (N=192), Trak. (N=44) 
 mean withers height of 166.1 ± 2.34cm, 
 age of 2.5 years 
 Illumina EquineSNP50® BeadChip 
 (54,602  42,642 SNPs) 
 single QTL region on ECA3 (LCORL/NCAPG)  




Conformation and functionality 
Body size: WH (III) 
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 GWAS: 214 Hanoverian WB horses; 
 1,851 horses from 42 breeds 
 (average withers height 83-170 cm) 
 Illumina EquineSNP50® BeadChip 
 (54,602  44,496 SNPs) 
 expression analysis: 
 47 horses from 5 breeds 
 significant association of relative 
LCORL expression levels with 
 SNP genotype (T>C mutation) and 
body size ('pony mutation' / ≤148cm) 
Feb 2013 
Conformation and functionality 
Body size (cont.) 
 model trait for studying genetic influences 
 on quantitative traits (within and across species) 
 importance across breeds of horses 
 distinct types of equine skeletal morphology 
 specific body size and shape variation patterns 
 within and across breeds 
 increase of knowledge on genetic size regulation: 
 LCORL (ligand-dependent nuclear receptor compressor-like protein) 
 consistent GWAS results in horses 
 Franches-Montagne horses (Signer-Hasler et al., 2012) 
 German warmblood horses (Kühn  et al., 2012 / Tetens et al., 2013; Metzger et al., 2013) 
 Arabs (Ricard et al., 2013) 
 multiple breeds and breed types (Metzger et al., 2013) 
 relevant size regulator across species 
 humans (Lango Allen et al., 2010), cattle (Pryce et al., 2011) 
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Health and disease 
Skeleton and locomotor system 
 major role of locomotor health for (long-term) usability of horses 
 some conditions with significant prevalences across breeds, e.g. 
juvenile osteochondral conditions (JOCC) (Denoix et al., 2013) 
 osteochondrosis (OC) 
 focal failure of enchondral ossification 
 considerable impact on the market value of horses 
 extensively studied worldwide for a long time 
 (clinics, populations genetics, molecular genetics) 
 multifactorial 
 accumulating knowledge 
 - faster now with the help of genomics 
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Denoix et al. (2013). Vet J 197, 29-35. 
Health and disease 
Skeleton and locomotor system: OC (I) 
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 1,162 young German WB stallions 
 radiographic protocols (binary OC/OCD) 
 Illumina EquineSNP50® BeadChip 
 (54,602  44,410 SNPs; 916 stallions) 
 distinct results for hock and fetlock / toe, 
indications of major QTL on ECA20 
 (OCD fetlock / toe) 
impact of trait definition! 
importance of specific & reliable 
phenotype information! 
Tetens et al. (2011). EAAP Annual Meeting, Starvanger, Norway. 
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Health and disease 
Skeleton and locomotor system: OC (II) 
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 583 French trotters 
 radiographic protocols (scores, binary) 
 Illumina EquineSNP50® BeadChip 
 (54,602  41,249 SNPs) 
 no evidence for major gene, 
 no common SNP associations for 
 hock OC (ECA3) and fetlock OC 
Teyssèdre et al. (2012). J Anim Sci 90, 45-53. 
impact of trait definition! 
importance of specific & reliable 
phenotype information! 
Health and disease 
Skeleton and locomotor system: OC (III) 
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 QTL for major OC/OCD conditions 
reported on >20 chromosomes 
 some chromosomes with >1 QTL 
 confirmed and new QTL in recent GWAS 
(50k / 70k SNP chips) 
Distl (2013). Vet J 197, 13-18. 
impact of trait definition & study design! 
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Health and disease 
Skeleton and locomotor system (cont.) 
 major role of locomotor health for (long-term) usability of horses 
 some conditions with significant prevalences across breeds, e.g. 
juvenile osteochondral conditions (JOCC) (Denoix et al., 2013) 
 osteochondrosis (OC) 
 focal failure of enchondral ossification 
 considerable impact on the market value of horses 
 extensively studied worldwide for a long time 
 (clinics, populations genetics, molecular genetics) 
 multifactorial 
 accumulating knowledge: set of distinct conditions 
 to be considered as different multigenic traits 
- OC and OCD in fetlock, hock and stifle joints 
- fetlock: dorsodistal osteochondral fragments (DOFs) 
- plantar osteochondral fragments (POFs) of hind limbs 
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Denoix et al. (2013). Vet J 197, 29-35. 
Health and disease 
Immune system 
 severe impact of immunologic dysfunction across species 
 defense mechanisms (infections) 
 autoimmune disorders 
 allergic reactions 
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Health and disease 
Immune system: ERU 
 severe impact of immunologic dysfunction across species 
 defense mechanisms (infections) 
 autoimmune disorders 
 allergic reactions  
 equine recurrent uveitis (ERU) 
 long-known eye condition 
 of significant prevalence in multiple breeds 
 most common cause of blindness in horses 
 link between Leptospira spp. and chronic 
 recurrence of intraoccular inflammation 
 current knowledge: 
 most likely autoimmune uveitis 
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 144 German WB horses 
 ERU score 0-3, binary 
 NERU0=65, NERU1-3=25+30+24 
 Illumina EquineSNP50® BeadChip 
 (54,602  37,040 SNPs) 
 significantly associated SNPs:  
 ECA20 (binary; IL-17A, IL-17F), 
 ECA18 (score; CRYGA-CRYGF) 
Kulbrock et al. (2013). PLoS ONE 8, e71619.  
Photo: http://www.davidlwilliams.org.uk 
Health and disease 
Immune system: IBH 
 severe impact of dysfunction across species 
 defense mechanisms (infections) 
 autoimmune disorders 
 allergic reactions  
 equine recurrent uveitis (ERU) 
 equine insect bite hypersensitivity (IBH) 
 long-known allergic skin condition 
 of significant prevalence in multiple breeds 
 link between Culicoides spp. and 
 chronic recurrence of skin inflammation 
 current knowledge: role of multiple genes 
related to immune function 
- ELA (equine leucocyte antigen) class II (Anderson et al., 2012) 
- IGHE (immunoglobulin heavy constant ε) (Wagner et al., 2001) 
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 187 Icelandic horses (SWE), 
 186 Exmoor ponies (UK) 
 94+80 cases, 93+106 controls 
 IBH status (binary) 
 Illumina EquineSNP50® BeadChip 
 (54,602  44,200 SNPs; only IH); 
microsatellites, sequence data 
 MHC class II region: 
 association of same variants and 
of regional homozygosity with 
 IBH susceptibility 
Andersson et al. (2012). Immunogenetics 64, 201-208. Wagner et al. (2001). Vet Immunol Immunopath 92,  193-202. 
Photo: http://www.vetnext.com 
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Health and disease 
Neurological function 
 highly complex interplay of peripheral and central nervous function 
 some very specific functional defects 
 understanding of regular function (across species) 
 often driven by studies of dysfunction (in target and model species) 
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Health and disease 
Neurological function: RLN (I) 
 highly complex interplay of peripheral and central nervous function 
 some very specific functional defects 
 understanding of regular function (across species) 
 often driven by studies of dysfunction (in target and model species) 
 recurrent laryngeal neuropathy (RLN) 
 obstructive condition of the upper respiratory tract 
 with possible impact on performance 
 link between body size and 'roaring' 
 current knowledge: 
 specific mononeuropathy with familial disposition 
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Photo: S. Brard 
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Health and disease 
Neurological function: RLN (II) 
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 531 horses 
 234 cases + 228 controls (incl. 196+188 WB), 
69 parents 
 endoscopic score for RLN 
 17 veterinary clinics in FRA, BEL, D, CH 
 Illumina EquineSNP50® BeadChip 
 (54,602  47,046 SNPs) 
 no evidence of major gene, but 
suggestive SNPs on ECA21 and ECA31 
 for WB (enrichment of 'protective' 
haplotype in controls) 
importance of specific & reliable 
phenotype information! 
Dupois  et al. (2011). Mamm Genome 22, 613-620. 
Health and disease 
Neurological function: Locomotion (I) 
 highly complex interplay of peripheral and central nerval function 
 some very specific functional defects 
 understanding of regular function (across species) 
 often driven by studies of specific function (in target and model species) 
 recurrent laryngeal neuropathy (RLN) 
 gaitedness and high-speed trotting 
 breed-specific ability to perform alternate gaits, 
 i.e. surplus to basic gaits (walk, trot, canter): 
 pace, ambling gaits (regular rhythm, lateral, diagonal ambling) 
 breed-specific ability to sustain trot at high speed, 
 i.e. delay transition into canter 
 related to general control / coordination 
 of limb movement 
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Photo: Andersson, 2012 
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Health and disease 
Neurological function: Locomotion (II) 
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 70 Icelandic horses 
 40 with pace (5-gaited), 30 without pace (4-gaited) 
 2 Icelandic horses 
 1 with pace (5-gaited, AA), 1 without pace (4-gaited, CC) 
 capability of pace (Y/N, competition records) 
 Illumina EquineSNP50® BeadChip 
 (54,602 SNPs), sequence data;  
 mouse model (wild-type and Dmrt3-null mice) 
 GWAS: strong association signal on ECA23 
 mutation detection: nonsense mutation C/A 
(transcription factor DMRT3) 
  premature stop codon 
 (truncated protein, 174 amino acids less) 
 DMRT3 gene expression: subset of inhibitory 
neurons in spinal cord (crossing dorsal midline, 
connecting to motor neurons) 
Andersson et al. (2012). Nature 488, 642-646. Andersson (2012). EAAP Annual Meeting, Bratislava, Slovakia. 
Health and disease 
Neurological function: Locomotion (III) 
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 ... 
 352 Icelandic horses, 
 176 gaited horses (6 breeds), 
 218 non-gaited horses (8 breeds), 
 414 horses bred for harness racing 
 high frequencies of DMRT3 mutation 
 in gaited and harness racing horses 
 DMRT3 mutation: 
 permissive for performing alternate gaits, 
i.e. pace or four-beat ambling gaits, and  
 high-speed trot ('gait keeper mutation') 
Andersson et al. (2012). Nature 488, 642-646. Andersson (2012). EAAP Annual Meeting, Bratislava, Slovakia. 
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Performance 
Racing and riding 
 performance criteria 
 mostly use-specific criteria in different horse breeds 
 (breed formation, generations of human selection) 
 some characteristics of relevance in either discipline 
 'total picture': 
 locomotion pattern, physiological characteristics, behavior, ... 
JAM 2014, Equine genomic research (STOCK et al.) 30 
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Performance 
Racing and riding: racing (I) 
 performance criteria 
 mostly use-specific criteria in different horse breeds 
 (breed formation, generations of human selection) 
 some characteristics of relevance in either discipline 
 'total picture': 
 locomotion pattern, physiological characteristics, behavior, ... 
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Ricard (submitted). 
 659 French trotters 
 trotting race records 
 (probability of qualification test, proportion of disqualified races, earnings) 
 DMRT3 genotyping; Illumina EquineSNP50® BeadChip 
 DMRT3: no fixation of AA genotype, 
 association of CC genotype with weaker performance 
 (QT probability , disqualification rate , earnings ),  
 intermediate results for CA genotype 
 (QT probability , earning of 5-years-olds ) 
 GWAS: some stronger associated SNPs 
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Performance 
Racing and riding: racing (II) 
 performance criteria 
 mostly use-specific criteria in different horse breeds 
 (breed formation, generations of human selection) 
 some characteristics of relevance in either discipline 
 'total picture': 
 locomotion pattern, physiological characteristics, behavior, ... 
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Ricard et al., (2013). 10th Internati. Equine Gene Mapping Workshop, Azores, Portugal, July 10-13, 2013. 
 597 Arabian endurance horses 
 endurance race records 
 (speed, distance, rates of finished races) 
 Illumina EquineSNP70® BeadChip 
 (74k  56,200 SNP) 
 no significantly associated SNPs for speed, 
 but 2 SNPs on ECA6 and 1 SNP on ECA7 for 
distance and finishing rates 
Performance 
Racing and riding: riding (I) 
 performance criteria 
 mostly use-specific criteria in different horse breeds 
 (breed formation, generations of human selection) 
 some characteristics of relevance in either discipline 
 'total picture': 
 locomotion pattern, physiological characteristics, behavior, ... 
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Schröder et al. (2011). Anim Genet 43, 392-400. 
 115 German WB stallions 
 breeding values for jumping 
 basis: scores for free jumping; BV range 56 - 171, reliability 0.87 
 Illumina EquineSNP50® BeadChip 
 (54,602  43,441 SNP) 
 QTL on ECA1, 8, 9 and 26, 
 further putative QTL on ECA 1, 3, 11, 17,217 
 genotype-based breeding values: 
 sum of additive and dominance effects of 6 SNPs 
explaining 54% of variance of conventional BV 
Photo: T. Ernst 
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Performance 
Racing and riding: riding (II) 
 performance criteria 
 mostly use-specific criteria in different horse breeds 
 (breed formation, generations of human selection) 
 some characteristics of relevance in either discipline 
 'total picture': 
 locomotion pattern, physiological characteristics, behavior, ... 
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Ricard et al. (2012). EAAP Annual Meeting, Bratislava, Slovakia. Ricard et al. (2013). J Anim Sci 91, 1076-1085. Brad & Ricard (submitted). 
 908+102 show-jumping horses, 289 3-day-event horses 
 (French sport horse, Anglo-Arabian, other European sport horses) 
 de-regressed breeding values  for competition performance 
 (basis: ranking and points, previously money earned) 
 Illumina EquineSNP50® BeadChip 
 (54,602  44,424 SNP for GWAS, 44,444 for GS) 
 GWAS: no evidence of major gene, but for show-jumping 
suggestive QTL on ECA1 (Ryanodine Receptor 2) 
 GS show-jumping (908 horses): only slight improvement of 
prediction accuracy (r²convGE=0.36, r²GS=0.39) Photo: Ricard et al., 2012 
 increasing complexity of phenotypes 
 implying increasing challenges (also) in genomic research 
 conformation and functionality 
 health and disease 
 performance 
 maximum use of the prospects of genomics 
 high standards for phenotyping 
 efficient use of resources 
 (samples, data, genomic tools, knowledge) 
 recent development of genomic research in horses in Europe 
 several initiatives with joint engagement of science and industry 
 national and international consortium partners 
 
Target traits & genomic approaches 
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Recent developments 
Danish project on GS 
 focus on performance and health 
 national consortium 
 (open for international collaboration) 
 selection of 500 horses for genotyping 
 DNA availability, low average relationship 
 EBV of as high as possible accuracy 
 competition, young horse performance, conformation (health) 
 strategy 
 moderate + high density genotyping 
 majority of horses 70k, few selected horses 670k 
 inclusion of genomic information 
 in regular breeding evaluations 
 phenotypes: young horse and competition results 
 single step procedure (challenge: proper scaling) 
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 heritable diseases of horses 
 with severe impact on the horse sector  
 international consortium: 
 BEL, SWE, UK, NL 
 strategy 
 samples over several breeds 
 samples sizes (cases+controls): 
 900+900 for insect bite hypersensitivity (IBH)  
 300+200 for chronic progressive lymphedema (CPL) 
 600+600 for osteochondrosis (OC) 
 identification of genes and genetic markers 
 high-density genotyping, 
 pooled genome sequencing (cases/controls), 
 sequencing of key ancestors and imputation 
 implementation of genomic selection 
 against disease susceptibility in breeding programs 
Photo: Http://www.horsegene.eu 
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Future of genomic research 
 expansion of collaboration in the equine sector in Europe 
 strengthening of the whole sector  
 clearly less concerns of the horse industry 
 to join efforts in the new field (genomics) 
 than in the traditionally studbook-specific breeding issues 
  expected: joint European research activity in equine genomics  
 scenarios for international collaboration 
 exchange of genotypes 
 genotyped sires used for breeding in several studbooks / countries 
 joint genomic evaluation 
 exchange of genotypes, phenotypes and pedigree information 
JAM 2014, Equine genomic research (STOCK et al.) 38 
IT-Solutions for 
Animal Production 
Thank you! 
